Click here to check out the new plexWell™ SARS-CoV-2 Sequencing application page and get started today with trial kit discounts (50% off).
About Us
seqWell was created to revolutionize NGS library prep to unlock the full potential of today’s DNA sequencing instruments.
Our plexWell™ platform is a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization. plexWell has wide-ranging impact on applications from synthetic biology, targeted sequencing and single-cell analysis to low and high depth sequencing of human, plant, animal and microbial genomes.
In addition to plexWell, seqWell is also developing library prep methods for reagent-based approaches for long-molecule phasing and read linking.
Management
Joseph Mellor, PhD
Founder and Chief Executive Officer
Erick Suh
Chief Commercial Officer
Jack T. Leonard, PhD
Chief Technology Officer
Tom Grant
Chief Financial Officer
Kerri Stellato
Vice President, Sales & Marketing
Chris Boggess
Vice President, Business Development
Ariele Hanek, PhD
Director, Research and Development
Matt Parisi
Director, Operations
Board of Directors
Scientific Advisors
Simone Picelli, PhD
Scientific Advisor
Jason Buenrostro, PhD
Scientific Advisor
Maryke Appel, PhD
Technical Consultant
Interested in joining our team?
We are always looking to add to our team. If you think you’d be a good fit for us, please email us at [email protected] to get in touch with someone about joining our team.